ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share (AVBP)

Q: What does CUSIP 04272N102 represent in this 13F holders report?

CUSIP 04272N102 is the security identifier for AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share used to aggregate holder disclosures.

Q: How many institutions held AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share in Q3 2026?

22 institutional investors reported AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share for Q3 2026. Use the holders table for investor-level position and value details.

CUSIP: 04272N102

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Common Stock, $0.0001 Par Value per Share
Total 13F shares: 263,840
Total 13F value: $7,982,419
Share change: +21,109
SEC-reported price per share: $30.28
Number of holders: 22
Value change: +$452,736
Number of buys: 15
Number of sells: 8
Shares outstanding: 49,454,020

Security key

04272N102

Report period

Q3 2026

Institutions

Top holders

AVBP full security history Ownership snapshot Full 13F holder table ArriVent BioPharma, Inc. SEC filings ArriVent BioPharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 04272N102

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MONTANOVA CAPITAL, LLC

Disclosed value leader

MONTANOVA CAPITAL, LLC

Comparable rows

10/15

Latest evidence

30 Jun 2026

13F 13D/G 3/4/5 Lead comparable stake: 9.9% 5 rows are not safely comparable across share classes. 13D/G row: MONTANOVA CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

MONTANOVA CAPITAL, LLC leads the comparable SEC ownership view at 9.9%.

10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MONTANOVA CAPITAL, LLC's linked filing trail.

Comparable ownership Top 5

MONTANOVA CAPITAL, LLC 9.9%

INFINITUM ASSET MANAGEMENT, LLC 9.9%

HILLHOUSE INVESTMENT MANAGEMENT, ... 9.5%

BlackRock, Inc. 6.8%

FMR LLC 6.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MONTANOVA CAPITAL, LLC	13F 13D/G Company · Suvretta Capital Management, LLC 13F 13D/G	9.9% Reported 13D/G · 30 Jun 2025	$156,869,547 4,515,531 shares	—	30 Jun 2026
INFINITUM ASSET MANAGEMENT, LLC	13F 13D/G Company 13F 13D/G	9.9% Reported 13D/G · 31 Dec 2025	$154,189,460 4,438,384 shares	—	30 Jun 2026
HILLHOUSE INVESTMENT MANAGEMENT, LTD.	3/4/5 13D/G 10%+ Owner 3/4/5 13D/G	9.5% Reported 13D/G · 31 Dec 2025	$91,823,464 3,929,117 shares	-$12,983,320	10 Dec 2025
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	6.8% Reported 13D/G · 30 Jun 2026	$112,918,757 3,250,396 shares	—	30 Jun 2026
FMR LLC	13F 13D/G Company 13F 13D/G	6.8% Reported 13D/G · 31 Mar 2026	$96,541,033 2,778,959 shares	—	30 Jun 2026
HBM Healthcare Investments (Cayman) Ltd.	13D/G 13D/G	5.4% Reported 13D/G · 08 Oct 2025	$40,491,643 2,195,014 shares	$0	08 Oct 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

263,840

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

156

Q3 2026 holders

Holder diff

-134

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend